Cabaletta Bio (CABA) Research & Development (2018 - 2026)

Cabaletta Bio's Research & Development history runs 8 years deep, the most recent figure standing at $140.8 million for Q4 2025.

• In Q4 2025, Research & Development rose 512.15% year-over-year to $140.8 million; the TTM figure through Dec 2025 stood at $179.6 million (up 145.67% YoY), while the FY2025 annual figure was $142.7 million, up 46.78% from the prior year.
• Research & Development for Q4 2025 stood at $140.8 million, up from $578000.0 in the prior quarter.
• The five-year high for Research & Development was $140.8 million in Q4 2025, with the low at -$36.6 million in Q4 2023.
• The 5-year median for Research & Development is $9.7 million (2021), against an average of $16.3 million.
• The sharpest annual moves came in 2023 and 2025: Research & Development slumped 395.48% in 2023, then surged 512.15% in 2025.
• Cabaletta Bio's Research & Development stood at $9.9 million in 2021, then increased by 25.01% to $12.4 million in 2022, then tumbled by 395.48% to -$36.6 million in 2023, then surged by 162.77% to $23.0 million in 2024, then soared by 512.15% to $140.8 million in 2025.
• Business Quant data shows CABA's Research & Development at $140.8 million in Q4 2025, $578000.0 in Q3 2025, and $37.6 million in Q2 2025.